Navigation Links
Immtech to Present at The Bank of Montreal Healthcare Conference
Date:12/3/2007

NEW YORK, Dec. 3 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (Amex: IMM) announced today that it will present at the Bank of Montreal (BMO) Capital Markets Focus on Healthcare Conference. On Tuesday, December 4, 2007 at 11:00am Eastern Time, Immtech is scheduled to present in the Biotechnology Room 4.04 -- the Millennium Broadway Hotel at 145 West 44th Street, New York City.

About Immtech Pharmaceuticals, Inc.

Immtech Pharmaceuticals, Inc. is focused on developing and commercializing drugs to treat infectious diseases, and the Company is expanding its targeted markets by applying its proprietary pharmaceutical platform to treat other disorders. Immtech has advanced clinical programs that include new oral treatments for pneumocystis pneumonia (PCP), malaria, and trypanosomiasis (HAT or African sleeping sickness), and a well defined, expanding library of compounds targeting drug-resistant Gram-positive bacteria, fungal infections, Hepatitis C and other serious diseases. Immtech holds the exclusive worldwide licenses to certain patents, patent applications and technology for products derived from a proprietary pharmaceutical platform. For additional information, please go to http://www.immtechpharma.com

"Safe Harbor" Statement under the Private Securities Reform Act of 1995: Statements in this press release regarding Immtech Pharmaceuticals, Inc.'s business, including the future prospects for PCP, which are not historical facts are "forward- looking statements" that involve risks and uncertainties. Actual results could differ materially from these forward-looking statements. Factors that could cause or contribute to such differences
'/>"/>

SOURCE Immtech Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
2. Avicena Group to Present at Noble Financial Conference
3. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
4. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
5. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
6. CEL-SCI to Present at the Noble Financial Conference
7. Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome
8. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
9. Strategic Diagnostics Updates Roth Conference Presentation Time
10. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
11. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)..., Company Introduces New Trade Name Onrigin(TM)... 4 VION PHARMACEUTICALS...ral announcements related to events in connection ...l Meeting at the Moscone Center in San Francisco f... Presentation , , The Company announced t...
(Date:12/4/2008)...OUNTAIN VIEW, Calif., Dec. 4 Based...tions, Frost & Sullivan recognizes Honeywell E... of the Year Award. Honeywell Enraf,s comprehensiv...an accurate mixture of fuels, chemicals and other ...jection rate. Honeywell Enraf,s blending equipment...
(Date:12/4/2008)...ARIS, December 4 ExonHit... diagnostic discovery company, is pleased to,anno...National Institute of,Industrial Property) during...,(Innovation Trophy). , "Since its incepti...and,to protect the value of its intellectual prop...
(Date:12/3/2008)..., - Additional Pipeline Product Agreement Execu...-, , , MONTREAL and BAGSVAERD, Denmark, De...ogies Inc. (TSX:CJB) and Novozymes Biopharma UK Lt...ced today that the Companies have entered into a l...ch Novozymes Biopharma will exclusively supply its...
Breaking Biology Technology:Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting 2Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting 3Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting 4Frost & Sullivan Commends Honeywell Enraf for Cutting-Edge Products and Post-Sales Support 2Frost & Sullivan Commends Honeywell Enraf for Cutting-Edge Products and Post-Sales Support 3ExonHit is Honoured by the "Innovation Trophy" From The National Institute of Industrial Property (INPI) 2ExonHit is Honoured by the "Innovation Trophy" From The National Institute of Industrial Property (INPI) 3ConjuChem and Novozymes Enter Long-Term Supply Agreement for Recombumin(R) use in PC-DAC(TM):Exendin-4 2ConjuChem and Novozymes Enter Long-Term Supply Agreement for Recombumin(R) use in PC-DAC(TM):Exendin-4 3
...i-Yu Lin, Bio-Rad Laboratories, , ...rmat for electroporation of mammalian tissue cultu...n than a single exponential decay , pulse...ponents of the , double pulse revealed th..., the first, high voltage pulse and not to ...
...i Tian, PhD, Bio-Rad Laboratories, 2000 Alfred,N... , The Benchmark Plus microplate reade... reader from Bio-Rad that offers superior conve...Benchmark Plus is controlled by Microplate Manager...igned in Microplate Manager software (version 5.1 ...
..., R. Geremia, M. Van,Montagu, and A. Herrera-Est...teit Gent, B-9000 Gent,Belgium, , ...l transformation protocols call for the addition o...glycol (PEG) following the initial , peri...uld also be useful , for introducing gene...
, , , , , , back to top
Other Biology Technology:Transient Gene Expression Following Single and Double Exponential Decay Electroporation Pulses 2Transient Gene Expression Following Single and Double Exponential Decay Electroporation Pulses 3Transient Gene Expression Following Single and Double Exponential Decay Electroporation Pulses 4Transient Gene Expression Following Single and Double Exponential Decay Electroporation Pulses 5Benchmark Plus Microplate Reader Scan Well Feature 2Benchmark Plus Microplate Reader Scan Well Feature 3Transformation of Filamentous Fungi by High-Voltage Electroporation 2Transformation of Filamentous Fungi by High-Voltage Electroporation 3Transformation of Filamentous Fungi by High-Voltage Electroporation 4Transformation of Filamentous Fungi by High-Voltage Electroporation 5Transformation of Filamentous Fungi by High-Voltage Electroporation 6Transformation of Filamentous Fungi by High-Voltage Electroporation 7Transformation of Filamentous Fungi by High-Voltage Electroporation 8
(Date:12/3/2008)...As the United States continues to develop alternat...dence, cellulosic-based ethanol has emerged as one...n stover remains the most popular source available...ated with the removal of corn fodder as a cellulos...nmental concern. , In the November-December 20...
(Date:12/3/2008)...of the first tandem mission between ERS-2 and Envi...ogether again to help improve our understanding of...and Envisat, the largest environmental satellite e...R) instruments that provide high resolution images...ore SAR images of the same site, slight alteration...
(Date:12/3/2008)...d as safe for pregnancy - other asthma drugs have ...ually keep using the same asthma drugs they were u...re the best studied and can be regarded as safe. M...ary however. According to the German Institute for...re data from trials could reassure women who worry...
(Date:12/2/2008)...ire/ -- Neurotechnology,( http://www.neurotechnol...,technologies, today announced that the Bangladesh...chnology to identify duplicate registrations in th...egistration Project registered,more than 80 milli...echnology.,After evaluating a number of biometric...
Breaking Biology News(10 mins):Managing carbon loss 2ESA satellites flying in formation 2Pregnant women with asthma can be more confident about some medicines 2Bangladesh Voter Registration Project Now Using MegaMatcher Biometric Technology to Detect and Prevent Duplicate Registrations 2Bangladesh Voter Registration Project Now Using MegaMatcher Biometric Technology to Detect and Prevent Duplicate Registrations 3New Data Support High Complete Remission Rates With VELCADE 28R 29 28Bortezomib 29 for Injection Based Therapies in Patients With Newly Diagnosed Mul 2105 1New Data Support High Complete Remission Rates With VELCADE 28R 29 28Bortezomib 29 for Injection Based Therapies in Patients With Newly Diagnosed Mul 2105 2New Data Support High Complete Remission Rates With VELCADE 28R 29 28Bortezomib 29 for Injection Based Therapies in Patients With Newly Diagnosed Mul 2105 3New Data Support High Complete Remission Rates With VELCADE 28R 29 28Bortezomib 29 for Injection Based Therapies in Patients With Newly Diagnosed Mul 2105 4New Data Support High Complete Remission Rates With VELCADE 28R 29 28Bortezomib 29 for Injection Based Therapies in Patients With Newly Diagnosed Mul 2105 5New Data Support High Complete Remission Rates With VELCADE 28R 29 28Bortezomib 29 for Injection Based Therapies in Patients With Newly Diagnosed Mul 2105 6New Data Support High Complete Remission Rates With VELCADE 28R 29 28Bortezomib 29 for Injection Based Therapies in Patients With Newly Diagnosed Mul 2105 7New Data Support High Complete Remission Rates With VELCADE 28R 29 28Bortezomib 29 for Injection Based Therapies in Patients With Newly Diagnosed Mul 2105 8Global Pharmaceutical Launches 3A Best Practices for Winning Product Launch Successes 19615 1Global Pharmaceutical Launches 3A Best Practices for Winning Product Launch Successes 19615 2Message to Nebraska Residents 3A Forgo Fad Dieting and Join the Campaign for Healthy Weight 19611 1Message to Nebraska Residents 3A Forgo Fad Dieting and Join the Campaign for Healthy Weight 19611 2Message to Nebraska Residents 3A Forgo Fad Dieting and Join the Campaign for Healthy Weight 19611 3Industry Executives Finding Value in Shift of Scientific Publications 5484 1Industry Executives Finding Value in Shift of Scientific Publications 5484 2
...ogists isolated a unique protein from jellyfish th... coli to pigs—and cause them to radiate a brillia...P) has allowed biologists to make many new discove...kingdom of life—plants—has presented special chall...walls and enormous subcellular structures that int...
...to glow is helping researchers at the University o...lls that are critical for the proper functioning o...ker protein may shed light on brain cell defects b...eases. The researchers describe how this marker wo... Journal of Neuroscience. , The marker gives scien...
...0-mile expedition across Tibet,s remote Chang Tang...gist George Schaller reports that the Tibetan ante... be increasing in numbers due to a combination of ...c in local communities. , The eight-week journey, ..., took place over a remarkably uninhabited region ...
...ls more economically competitive with fossil fuels...r cellulosic ethanol production, one major detour ...he genetic blueprint of the fungus Pichia stipitis...stitute (DOE JGI) and collaborators at the U.S. Fo...he research, entailing the identification of numer...
Other Biology News:Researchers develop marker that identifies energy-producing centers in nerve cells 2Tibetan antelope slowly recovering, WCS says 2Super-fermenting fungus genome sequenced 2